デフォルト表紙
市場調査レポート
商品コード
1671860

ヒト初代細胞培養市場:製品タイプ別、細胞タイプ別、用途別、エンドユーザー別

Human Primary Cell Culture Market, By Product Type, By Cell Type, By Application, By End User


出版日
ページ情報
英文 156 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヒト初代細胞培養市場:製品タイプ別、細胞タイプ別、用途別、エンドユーザー別
出版日: 2025年01月16日
発行: Coherent Market Insights
ページ情報: 英文 156 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ヒト初代細胞培養の世界市場は、2025年には41億米ドルと推定され、2032年には86億1,000万米ドルに達すると予測され、2025年から2032年までのCAGRは11.2%です。

レポート範囲 レポート詳細
基準年 2024 2025年の市場規模 41億米ドル
実績データ 2020年から2024年まで 予測期間 2025年から2032年
予測期間:2025年~2032年 CAGR: 11.20% 2032年の価値予測 86億1,000万米ドル
図.ヒト初代細胞培養市場シェア(%)、地域別、2025年
Human Primary Cell Culture Market-IMG1

ヒト初代細胞培養とは、人工的に制御された環境で、体内から直接取り出したヒト細胞や組織を培養することを指します。過去数十年の間に、ヒト初代細胞を分離・培養する技術は著しく進歩しました。初代細胞培養によって、研究者は個々の細胞タイプや様々な刺激に対する反応を、生体の外にある皿の中で研究することができます。これによって、研究における動物やヒト被験者の使用を減らすと同時に、疾患プロセスに関する洞察を得たり、潜在的な治療薬を試験したりすることができます。初代細胞は、その由来となる生体内の特定の細胞の特徴を保持し、生体内のものと類似した代謝を持っています。世界のヒト初代細胞培養市場は、がん、幹細胞、組織工学、創薬に関連する調査への幅広い応用により、牽引力を増しています。

市場力学:

世界のヒト初代細胞培養市場は、医薬品の研究開発活動の活発化、ヘルスケア研究に対する政府支出の増加、慢性疾患の蔓延によって牽引されています。初代細胞培養は、がんのような様々な疾患に対する個別化医薬品の開発において重要な役割を果たしています。しかし、分離手順のコストが高く、細胞培養ラボのインフラ要件が市場の成長を制限しています。初代細胞を扱う熟練した専門家の不足も課題となっています。プラス面では、生体内の微小環境をよりよく模倣する培養培地処方の技術的進歩が機会を提供しています。3Dバイオプリンティング技術の開発や初代細胞を利用した臓器オンチッププラットフォームの開発は、予測期間中の市場拡大をさらに後押しすると思われます。

本調査の主な特徴

本レポートは、世界のヒト初代細胞培養市場を詳細に分析し、2024年を基準年とした予測期間(2025-2032年)の市場規模および複合年間成長率(CAGR%)を提供しています。

また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて解説しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

世界のヒト初代細胞培養市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。

本調査の対象となる主要企業には、 Thermo Fisher Scientific、Merck KGaA、Lonza Group、Danaher Corporation、Becton、Dickinson and Company、Corning Incorporated、Sartorius AG、GE Healthcare、Fujifilm Irvine Scientific、Sigma-Aldrich (Merck)、PromoCell GmbH、ATCC (American Type Culture Collection)、Cell Biologics、InVivo Biosystems、Stemcell Technologies などが含まれます。

このレポートから得られる洞察により、企業のマーケティング担当者や経営幹部は、将来の製品の発売、タイプのアップグレード、市場の拡大、マーケティング戦略に関して情報に基づいた意思決定を行うことができます。

この調査レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者を対象としています。

利害関係者は、世界のヒト初代細胞培養市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

  • 調査目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー

第3章 市場力学、規制、動向分析

  • 市場力学
  • 促進要因
  • 抑制要因
  • 機会
  • 影響分析
  • 主な発展
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ
  • 業界動向

第4章 世界のヒト初代細胞培養市場、製品タイプ別、2020年~2032年

  • 一次細胞
  • 器械
  • 試薬とサプリメント
  • 初代細胞培養培地
  • その他の消耗品

第5章 世界のヒト初代細胞培養市場、細胞タイプ別、2020年~2032年

  • ヒト初代細胞
  • 動物の初代細胞

第6章 世界のヒト初代細胞培養市場、用途別、2020年~2032年

  • 細胞・遺伝子治療の開発
  • ワクチン製造
  • 医薬品の発見と開発
  • がん調査
  • 出生前診断
  • その他

第7章 世界のヒト初代細胞培養市場、エンドユーザー別、2020年~2032年

  • 製薬・バイオテクノロジー企業
  • 学術調査機関
  • 契約調査機関(CRO)
  • その他

第8章 世界のヒト初代細胞培養市場、地域別、2020年~2032年

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア太平洋
  • 中東
  • アフリカ

第9章 競合情勢

  • Thermo Fisher Scientific
  • Merck KGaA
  • Lonza Group
  • Danaher Corporation
  • Becton, Dickinson and Company
  • Corning Incorporated
  • Sartorius AG
  • GE Healthcare
  • Fujifilm Irvine Scientific
  • Sigma-Aldrich(Merck)
  • PromoCell GmbH
  • ATCC(American Type Culture Collection)
  • Cell Biologics
  • InVivo Biosystems
  • Stemcell Technologies

第10章 アナリストの推奨事項

  • 運命の輪
  • アナリストの見解
  • 一貫した機会マップ

第11章 参考文献と調査手法

  • 参考文献
  • 調査手法
  • 出版社について
目次
Product Code: CMI7724

The Global Human Primary Cell Culture Market is estimated to be valued at USD 4.10 Bn in 2025 and is expected to reach USD 8.61 Bn by 2032 exhibiting a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 4.10 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 11.20% 2032 Value Projection: USD 8.61 Bn
Figure. Human Primary Cell Culture Market Share (%), By Region, 2025
Human Primary Cell Culture Market - IMG1

Human primary cell culture refers to the practice of growing human cells and tissues directly extracted from the body in an artificial controlled environment. Over the past few decades, techniques of isolating and culturing primary human cells have advanced significantly. Primary cell cultures allow researchers to study individual cell types and their responses to various stimuli in a dish, outside a living organism. This reduces the use of animal and human subjects in research while providing insights into disease processes and testing potential therapeutic agents. Primary cells retain characteristics of the specific cell in the body from which they are derived and have metabolism resembling their in vivo counterparts. The global human primary cell culture market has been gaining traction due to its wide application in research related to cancer, stem cells, tissue engineering, and drug discovery.

Market Dynamics:

The global human primary cell culture market is driven by rising pharmaceutical R&D activities, increasing governmental expenditure on healthcare research, and growing prevalence of chronic diseases. Primary cell culture plays a critical role in developing personalized medicines for various conditions like cancer. However, high cost of isolation procedures and infrastructure requirements for cell culture laboratories limit the market growth. Shortage of skilled professionals to handle primary cells also poses a challenge. On the positive side, technological advancements in culture media formulations that better mimic the in vivo microenvironment offer opportunities. Adoption of 3D bioprinting techniques and development of organ-on-chip platforms utilizing primary cells would further support the market expansion during the forecast period.

Key Features of the Study:

This report provides in-depth analysis of the global human primary cell culture market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global human primary cell culture market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Thermo Fisher Scientific, Merck KGaA, Lonza Group, Danaher Corporation, Becton, Dickinson and Company, Corning Incorporated, Sartorius AG, GE Healthcare, Fujifilm Irvine Scientific, Sigma-Aldrich (Merck), PromoCell GmbH, ATCC (American Type Culture Collection), Cell Biologics, InVivo Biosystems, and Stemcell Technologies

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global human primary cell culture market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global human primary cell culture market

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Primary Cells
    • Instruments
    • Reagents and Supplements
    • Primary Cell Culture Media
    • Other Consumables
  • Cell Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Human Primary Cells
    • Animal Primary Cells
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Cell & Gene Therapy Development
    • Vaccine Production
    • Drug Discovery and Development
    • Cancer Research
    • Prenatal Diagnosis
    • Others
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Pharmaceutical and Biotechnology Companies
    • Academic and Research Institutions
    • Contract Research Organizations (CROs)
    • Others
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Thermo Fisher Scientific
    • Merck KGaA
    • Lonza Group
    • Danaher Corporation
    • Becton, Dickinson and Company
    • Corning Incorporated
    • Sartorius AG
    • GE Healthcare
    • Fujifilm Irvine Scientific
    • Sigma-Aldrich (Merck)
    • PromoCell GmbH
    • ATCC (American Type Culture Collection)
    • Cell Biologics
    • InVivo Biosystems
    • Stemcell Technologies

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Human Primary Cell Culture Market, By Product Type
    • Global Human Primary Cell Culture Market, By Cell Type
    • Global Human Primary Cell Culture Market, By Application
    • Global Human Primary Cell Culture Market, By End User
    • Global Human Primary Cell Culture Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Human Primary Cell Culture Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Primary Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Reagents and Supplements
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Primary Cell Culture Media
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Other Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Human Primary Cell Culture Market, By Cell Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Human Primary Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Animal Primary Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Human Primary Cell Culture Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Cell & Gene Therapy Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Vaccine Production
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Drug Discovery and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cancer Research
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Prenatal Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Human Primary Cell Culture Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical and Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Academic and Research Institutions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Human Primary Cell Culture Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Cell Type , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User , 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck KGaA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Lonza Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton, Dickinson and Company
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Corning Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sartorius AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GE Healthcare
  • Fujifilm Irvine Scientific
  • Sigma-Aldrich (Merck)
  • PromoCell GmbH
  • ATCC (American Type Culture Collection)
  • Cell Biologics
  • InVivo Biosystems
  • Stemcell Technologies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us